Walker B B, Sandman C A
Am J Ment Defic. 1979 Jan;83(4):346-52.
In a double-blind procedure, 24 mentally retarded adults received 0 mg, 5mg, or 20 mg of an analog of the neuropeptide ACTH 4--9. Following treatment with peptide, the subjects were given the Trails B Test (from the Halstead-Reitan Neuropsychological Battery), the Peabody Picture Vocabulary test, the Benton Visual Retention Test, a concept-formation task, and a standard orienting sequence. The results of the behavioral tests suggested that attentional processes were enhanced in subjects treated with the peptide. The present study, in conjunction with another investigation using the neuropeptide ACTH/MSH 4--10 (Sandman, George, Walker, Nolan & Kastin, 1976), indicates that attentional deficits in mentally retarded adults, traditionally assumed to be irreversible, may be influenced by treatment with fragments of the neuropeptides ACTH and MSH.
在一项双盲实验中,24名智力发育迟缓的成年人分别接受了0毫克、5毫克或20毫克的神经肽促肾上腺皮质激素4-9类似物。肽治疗后,对受试者进行了B型连线测验(来自霍尔斯特德-赖坦神经心理成套测验)、皮博迪图片词汇测验、本顿视觉保持测验、概念形成任务以及标准定向序列测试。行为测试结果表明,接受肽治疗的受试者注意力过程得到了增强。本研究与另一项使用神经肽促肾上腺皮质激素/促黑素细胞激素4-10的调查(桑德曼、乔治、沃克、诺兰和卡斯廷,1976年)共同表明,传统上认为智力发育迟缓成年人的注意力缺陷是不可逆转的,但可能会受到促肾上腺皮质激素和促黑素细胞激素片段治疗的影响。